We have been made aware that the recent coronavirus (COVID-19) outbreak is making it difficult for laboratories across the world to deliver core services. With this in mind, we will be extending trial deadlines for all new trials issued by one week. If you are still unable to provide a result within this extended timeframe, or you are unable to return results in currently live trials, please do not hesitate to contact us at admin@ukneqasli.co.uk and we will do everything we can to help.

The UK NEQAS LI Re-Registration window for 2020/2021 is now open. Please click on the 'Re-Registration, Data Entry and Reports/Participant Hub' button above to re-register.

Please see the link below detailing the UK NEQAS position on Brexit.

https://ukneqas.org.uk/news/uk-neqas-brexit-update-2/

Thank you.

Due to the current COVID-19 pandemic, the decision has been taken to postpone the Scientific Meeting which had been due to take place in June 2020. This will be rescheduled for early next year and further information will follow in due course. 

We apologise for any inconvenience caused and thank you for your understanding.

RCPath are looking for experienced professionals with experience in technical EQA to join their workstreams.

For further information on this process and details on how to apply please follow this link: 

https://www.rcpath.org/discover-pathology/news/tbc.html

As part of our commitment to develop the services and External Quality Assessment (EQA) programmes provided by this centre we are redesigning the Leukaemia Immunophenotyping (LI) programme to better reflect current hospital laboratory testing protocols. These changes are based on the format and findings from educational exercises A and B, previously issued within this programme.

For more information, please click on the link below.

For information on UK NEQAS LI services and the impact of Brexit, please read our official statement by clicking on the link below.

Sheffield Teaching Hospitals NHS Foundation Trust, a UKAS accredited proficiency testing provider No. 7804, operating UK NEQAS for Leucocyte Immunophenotyping.

You can find our schedule of accreditation here.

Also a link to the UKAS website can be found here, where you will be able to view and download a PDF of our current accreditation certificate.

UK NEQAS for Leucocyte Immunophenotyping (UK NEQAS LI) now has a Facebook page and a Twitter account. We will be posting important messages to these accounts relating to our schemes so please like or follow us, respectively.

We hope that these feeds will act as a useful eductational resource for participants and collaborators alike, collating interesting papers, conference info, videos and news stories in haemato-oncology. As we develop our online presence we hope to publish some of our own educational content. If you have any feedback or ideas as to content you would like us to include, please do not hesitate to get in touch.